![Kent Boles](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Kent Boles is the head of technology at Lassogen, Inc. which he founded in 2019.
Actieve functies van Kent Boles
Bedrijven | Functie | Begin |
---|---|---|
Lassogen, Inc.
![]() Lassogen, Inc. Internet Software/ServicesTechnology Services Lassogen, Inc. operates as a preclinical biotechnology company. It develops lasso peptides as a new therapeutic modality for diagnosing and treating intractable health challenges. The company was founded by Mark J. Burk, Douglas Mitchell, Tracy Handel and Kent Boles in 2019 and is headquartered in San Diego, CA. | Oprichter | 01-01-2019 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Lassogen, Inc.
![]() Lassogen, Inc. Internet Software/ServicesTechnology Services Lassogen, Inc. operates as a preclinical biotechnology company. It develops lasso peptides as a new therapeutic modality for diagnosing and treating intractable health challenges. The company was founded by Mark J. Burk, Douglas Mitchell, Tracy Handel and Kent Boles in 2019 and is headquartered in San Diego, CA. | Technology Services |